Pyridoxine

CAS No. 65-23-6

Pyridoxine( —— )

Catalog No. M15477 CAS No. 65-23-6

Pyridoxine is the 4-methanol form of vitamin B6 and is converted to pyridoxal 5-phosphate in the body.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
100MG 36 In Stock
200MG Get Quote In Stock
500MG 85 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pyridoxine
  • Note
    Research use only, not for human use.
  • Brief Description
    Pyridoxine is the 4-methanol form of vitamin B6 and is converted to pyridoxal 5-phosphate in the body.
  • Description
    Pyridoxine is the 4-methanol form of vitamin B6 and is converted to pyridoxal 5-phosphate in the body. Although pyridoxine and vitamin B6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading. (In Vitro):Pyridoxine exerts a protective potential against AD, attenuates ROS levels, decreases the expressions of cytoplasmic Nrf2, and upregulates whole-cell HO-1 expression.
  • In Vitro
    Pyridoxine exerts a protective potential against AD, attenuates ROS levels, decreases the expressions of cytoplasmic Nrf2, and upregulates whole-cell HO-1 expression.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PLK
  • Recptor
    PLK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    65-23-6
  • Formula Weight
    169.18
  • Molecular Formula
    C8H11NO3
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    CC1=NC=C(CO)C(CO)=C1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Adams JB, et al. J Altern Complement Med. 2006 Jan-Feb;12(1):59-63.
molnova catalog
related products
  • Tebanicline

    Tebanicline (ABT-594, Ebanicline) acts as a partial agonist at neuronal nicotinic acetylcholine receptors, binding to both the α3β4 and the α4β2 subtypes.

  • Rigosertib sodium

    Rigosertib sodium (ON 01910.Na) is a potent, non-ATP-competitive PLK1 inhibitor (IC50=9-10 nM).

  • RO 3280

    RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1)